BioSpace News Archive

According to a recent article in the International Journal of Spine Surgery, advanced decompression innovator Carevature’s Dreal™ device yields significantly better results in incidental dural tears, with 87% improvement compared to high-speed drills and Kerrison Rongeurs (0.4% vs. 2.91%; p<0.01); and 80% improvement compared to ultrasonic bone cutters (0.4% vs. 1.95%; p<0.01).

Waters Corporation (NYSE:WAT) Chris O’Connell, Chairman and Chief Executive Officer, will speak to the investment community at the Morgan Stanley 16th Annual Global Healthcare Conference to be held at the Grand Hyatt New York, Wednesday, September 12, at 9:55 AM Eastern Time.

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, announced today that it will participate in the Bank of America Merrill Lynch Global Healthcare Conference.

Over 20 health care companies have formed the Da Vinci Project, a private-sector initiative that is leveraging HL7 Fast Healthcare Interoperability Resources (FHIR®) to improve data sharing in value-based care (VBC) arrangements via two initial test cases.

Paradigm Outcomes, the market leader in managing catastrophic and complex cases for the workers’ compensation industry, today announced it has acquired Adva-Net, a leading ancillary network for high-acuity workers’ compensation claims, providing services for comprehensive pain management, post-acute care management and addiction recovery.

Synergy Billing announced today that the company is launching the Synergy Revenue Recovery Service.

Stand Up To Cancer’s sixth biennial telecast on Friday, September 7th (8:00 - 9:00 PM ET/PT) has added more names to its star-studded lineup.

Patient engagement leader PatientPoint® and the Testicular Cancer Society today announced a partnership that will bring trusted testicular cancer education to thousands of patients and caregivers in physician offices nationwide.

Cricket Health, a tech-enabled provider of integrated kidney care, announced today that it has closed a Series A funding round of $24 million.

Prometic Life Sciences Inc. reported today that it will host a Key Opinion Leader meeting on PBI-4050, a novel treatment for Alström Syndrome (AS) and a promising therapeutics candidate for the treatment of non-alcoholic steatohepatitis (NASH) on Friday, September 7th in New York City.